Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Citi
Cantor Fitzgerald
AstraZeneca
Chinese Patent Office
Harvard Business School
Colorcon
Farmers Insurance
US Army

Generated: October 17, 2017

DrugPatentWatch Database Preview

Suppliers and packages for NDA: 021515

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDAValeant Pharmaceuticals North America LLC0187-0730-077 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDAValeant Pharmaceuticals North America LLC0187-0730-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDAValeant Pharmaceuticals North America LLC0187-0730-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-90)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDAValeant Pharmaceuticals North America LLC0187-0731-077 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0731-07)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDAValeant Pharmaceuticals North America LLC0187-0731-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0731-30)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDASTAT Rx USA LLC16590-246-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-246-30)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDARebel Distributors Corp21695-137-1515 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-137-15)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDARebel Distributors Corp21695-137-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-137-30)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDARebel Distributors Corp21695-137-4545 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-137-45)
Valeant Intl
WELLBUTRIN XL
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL021515NDARebel Distributors Corp21695-138-1515 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-138-15)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Deloitte
McKesson
Healthtrust
UBS
Baxter
AstraZeneca
Express Scripts
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot